Method for preventing HIV-1 infection of CD4+ cells

Details for Australian Patent Application No. 2003200133 (hide)

Owner Progenics Pharmaceuticals, Inc.

Inventors Olson, William C.; Maddon, Paul J.; Litwin, Virginia M.; Allaway, Graham P.

Agent Davies Collison Cave

Pub. Number AU-A-2003200133

Parent 81426

Filing date 16 January 2003

Wipo publication date 17 April 2003

International Classifications

A61K 039/00 Medicinal preparations containing antigens or antibodies

C07K 014/54 Peptides having more than 20 amino acids

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C12Q 001/70 Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

30 January 2003 Complete Application Filed

17 April 2003 Application Open to Public Inspection

  Published as AU-A-2003200133

22 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003200134-Multiple component container and method of molding same

2003200132-Method for detecting pathogenic prion proteins by means of mass spectroscopy